← Leaderboards
Susan H Eshleman
Johns Hopkins University
$103,346,426
Attributed
$117,988,948
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $14.8M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$117,988,948 · 7
By mechanism
UM1$91,183,797 · 1
U01$16,539,477 · 1
R01$9,989,444 · 3
R03$163,180 · 1
R29$113,050 · 1
Top collaborators
- Ronald S Brookmeyer4 shared
- Mark A Marzinke4 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- William J Moss$14,737,348
- Roger H Reeves$24,667,280
- Tiara C. Willie$5,013,175
- Deborah Persaud$30,632,571
- Mark A Marzinke$21,162,682
Others in their field
Top investigators on “Aids Prevention”
- Judith S. Currier · University Of California Los Angeles$494,857,170
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$398,787,960
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$310,253,675
- Lawrence Corey · Fred Hutchinson Cancer Center$298,388,501
- Constance Ann Benson · University Of California, San Diego$291,928,206
- Daniel R Kuritzkes · Brigham And Women'S Hospital$281,830,629
Research focus
Aids PreventionDesignHiv InfectionsPreventionLaboratoriesAfricaTransmission ProcessAnti-Retroviral AgentsPerformanceHiv Prevention Trials NetworkPharmaceutical PreparationsCommunitiesAfrica South Of The SaharaSamplingAsiaPrevention ResearchPrevention StrategyPopulations At RiskBehavioralLeadershipMen Who Have Sex With MenInternationalMissionSite
Grant awards (43)
LC: HIV PREVENTION TRIALS NETWORK$8,531,038
UM1 · FY2025 · AI · contact PI
LC: HIV PREVENTION TRIALS NETWORK$4,024,293
UM1 · FY2024 · AI · contact PI
LC: HIV PREVENTION TRIALS NETWORK$6,974,239
UM1 · FY2023 · AI · contact PI
LC: HIV PREVENTION TRIALS NETWORK$6,848,077
UM1 · FY2022 · AI · contact PI
LC: HIV PREVENTION TRIALS NETWORK$11,779,883
UM1 · FY2021 · AI · contact PI
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)$2,331,636
UM1 · FY2021 · AI · contact PI
HIV incidence testing in an evolving epidemic: Identification of accurate multi-assay algorithms that include serosignatures from a novel antibody profiling system.$695,133
R01 · FY2021 · AI · contact PI
LC: HIV Prevention Trials Network$3,027,715
UM1 · FY2020 · AI · contact PI
HIV incidence testing in an evolving epidemic: Identification of accurate multi-assay algorithms that include serosignatures from a novel antibody profiling system.$708,682
R01 · FY2020 · AI · contact PI
LC: HIV Prevention Trials Network - Laboratory Support for the SARS-CoV-2 Seroprevalence Study (CoVPN 5002)$167,145
UM1 · FY2020 · AI · contact PI
LC: HIV Prevention Trials Network$5,668,821
UM1 · FY2019 · AI · contact PI
HIV incidence testing in an evolving epidemic: Identification of accurate multi-assay algorithms that include serosignatures from a novel antibody profiling system.$727,681
R01 · FY2019 · AI · contact PI
LC: HIV Prevention Trials Network$4,349,197
UM1 · FY2018 · AI · contact PI
HIV incidence testing in an evolving epidemic: Identification of accurate multi-assay algorithms that include serosignatures from a novel antibody profiling system.$742,649
R01 · FY2018 · AI · contact PI
LC: HIV Prevention Trials Network$4,245,488
UM1 · FY2017 · AI · contact PI
HIV incidence testing in an evolving epidemic: Identification of accurate multi-assay algorithms that include serosignatures from a novel antibody profiling system.$768,641
R01 · FY2017 · AI · contact PI
LC: HIV Prevention Trials Network$5,663,547
UM1 · FY2016 · AI · contact PI
LC: HIV Prevention Trials Network$6,993,955
UM1 · FY2015 · AI · contact PI
LC: HIV Prevention Trials Network$7,306,283
UM1 · FY2014 · AI · contact PI
Laboratory and Statistical Development of Cross-Sectional HIV Incidence Assays$730,270
R01 · FY2014 · AI · contact PI
HIV Prevention Trials Network: Network Laboratory$1,777,536
UM1 · FY2013 · AI · contact PI
HIV Prevention Trials Network: Network Laboratory$1,074,961
UM1 · FY2013 · AI · contact PI
Laboratory and Statistical Development of Cross-Sectional HIV Incidence Assays$686,668
R01 · FY2013 · AI · contact PI
Impact of maternal HAART on HIV-infected breastfeeding infants: Malawi$583,897
R01 · FY2013 · AI · contact PI
HIV Prevention Trials Network: Network Laboratory$5,037,579
UM1 · FY2012 · AI · contact PI
Laboratory and Statistical Development of Cross-Sectional HIV Incidence Assays$730,497
R01 · FY2012 · AI · contact PI
Impact of maternal HAART on HIV-infected breastfeeding infants: Malawi$606,298
R01 · FY2012 · AI · contact PI
HIV Prevention Trials Network: Network Laboratory$5,382,404
UM1 · FY2011 · AI · contact PI
Laboratory and Statistical Development of Cross-Sectional HIV Incidence Assays$759,963
R01 · FY2011 · AI · contact PI
Impact of maternal HAART on HIV-infected breastfeeding infants: Malawi$607,126
R01 · FY2011 · AI · contact PI
HIV Prevention Trials Network: Network Laboratory$2,654,477
U01 · FY2010 · AI · contact PI
Impact of maternal HAART on HIV-infected breastfeeding infants: Malawi$611,887
R01 · FY2010 · AI · contact PI
Resistance in HIV-infected infants after extended ARV prophylaxis: PEPI-Malawi$81,180
R03 · FY2010 · HD · contact PI
HIV Prevention Trials Network: Network Laboratory$4,116,871
U01 · FY2009 · AI · contact PI
Resistance in HIV-infected infants after extended ARV prophylaxis: PEPI-Malawi$82,000
R03 · FY2009 · HD · contact PI
HIV Prevention Trials Network: Network Laboratory$3,273,493
U01 · FY2008 · AI · contact PI
HIV Prevention Trials Network: Network Laboratory$3,396,430
U01 · FY2007 · AI · contact PI
HIV Prevention Trials Network: Network Laboratory$3,098,206
U01 · FY2006 · AI · contact PI
Drug Resistance in Non-Subtype B HIV-1$257,513
R01 · FY2005 · HD
Drug Resistance in Non-Subtype B HIV-1$257,513
R01 · FY2004 · HD
Drug Resistance in Non-Subtype B HIV-1$257,513
R01 · FY2003 · HD
Drug Resistance in Non-Subtype B HIV-1$257,513
R01 · FY2002 · HD
V3 REGION DIVERSITY IN HIV VERTICAL TRANSMISSION: UGANDA$113,050
R29 · FY2000 · HD